OR WAIT null SECS
November 21, 2019
Fujifilm Diosynth Biotechnologies will add a new building, including gene therapy laboratories, to its facility in College Station, TX.
October 15, 2019
Lonza, through its Ibex Solutions, will now cover preclinical and clinical development and manufacturing for a significant portion of Genmab’s pipeline.
October 10, 2019
Biotechnology company, Avacta Group, and clinical-stage oncology-focused biotech, ADC Therapeutics, have entered into a collaboration and option agreement focused on the development of potent Affimer-drug conjugates.
October 08, 2019
The new services provide rapid production of antibody drug conjugates (ADCs) for best candidate selection.
September 09, 2019
The new antibody, Citryll’s CIT-013, could offer new treatment options for various human diseases including lupus, vasculitis, pulmonary fibrosis, and organ damage due to sepsis.
September 03, 2019
The partnership will provide cost effective biologics for the world market.
The joint venture, named BacThera, will operate out of headquarters in Basel, Switzerland and will serve pre-clinical to Phase II projects, with the ability to expand to Phase III and commercial manufacturing in the future.
September 01, 2019
CDMOs are adding facilities and services to their portfolios in anticipation of the biologics industry’s continued growth.
August 30, 2019
Alvotech and Prestige Biopharma, have announced the formation of a new contract manufacturing partnership for the commercial production of a biosimilar.
August 14, 2019
The companies have entered into a manufacturing agreement for the production of Phase III clinical trial material.